Indoco Remedies Limited
Indoco Remedies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: INDOCO and BSE: 532612 (ISIN INE873D01024).
It has a market capitalisation of ₹2,183 crore, a last close of ₹236.50 on 2026-10-19, a one-year return of -17.1%.
Valuation: a price-to-earnings ratio of 388x, a price-to-book ratio of 2.32x, a dividend yield of 0.1%.
Profitability: return on equity of -9.7%, return on capital employed of 1.0%, an operating margin of 8.8%.
Growth: sales growth of 3.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 1.10x, promoter holding of 58.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,183 |
| Last close | ₹236.50 |
| P/E (TTM) | 388x |
| P/B | 2.32x |
| Dividend yield | 0.1% |
| ROE (FY) | -9.7% |
| ROCE (FY) | 1.0% |
| Operating margin (TTM) | 8.8% |
| Sales growth, 3-year CAGR | 3.4% |
| Debt / equity | 1.10x |
| Promoter holding | 58.9% |
| 1-year return | -17.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means